Differential clinical prognostic classifications in dilated and ischemic advanced heart failure: The EPICAL study

American Heart Journal

Volumn 139, Issue 5, 2000, Pages 895-904

  Alla, François ^a   Briançon, Serge ^a   Juillière, Yves ^a   Mertes, Paul M ^a   Villemot, Jean P ^a   Zannad, Faiez ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b The Lorraine Hospitals   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HEART DILATATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE;

EID: 0034066885     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(00)90023-1     Document Type: Article

References (33)

1. 1. Anguita M, Arizon JM, Bueno G, et al. Clinical and hemodynamic predictors of survival in patients aged <65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1993;72:413-7.
2. 2. Saxon L, Stevenson WG, Middlekauff HR, et al. Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Arn J Cardiol 1993;72:62-5.
3. 3. Bigger JTJ. Why patients with congestive heart failure die: arrythmias and sudden cardiac death. Circulation 1987,75:28-35.
4. 4. Campana C, Gavazzi A, Berzuini C, et al. Predictors of prognosis in patients awaiting heart transplantation. J Heart Lung Transplant 1993; 12:756-65.
5. 5. Zannad F, Briançon S, Juillière Y, et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study. J Am Coll Cardiol 1999;33:734-42.
6. 6. Stevenson WG, Stevenson LW, Middlekauff HR, et al. Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol 1995;26:1417-23.
7. 7. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984,311:819-23.
8. 8. Parameshwar J, Keegan J, Sparrow J, et al. Predictors of prognosis in severe chronic heart failure. Am Heart J 1992,123:421-6.
9. 9. Massie BM, Conway M. Survival of patients with congestive heart failure: past, present, and future prospects. Circulation 1987,75:11-8.
10. 10. Gradman AH, Deeswania PC. Predictors of mortality in patients with heart failure. Cardiol Clin 1994; 12:25-35.
11. 11. Ikram H, Williamson HG, Won M, et al. The course of idiopathic dilated cardiomyopathy in New Zealand. Br Heart J 1987;57:521-7.
12. 12. Poses RM, Smith WR, McClish DK, et al. Physicians' survival predictions for patients with acute congestive heart failure. Arch Intern Med 1997; 157:1001-7.
13. 13. Brophy JM, Deslauriers G, Rouleau JL. Long term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol 1994;10:543-7.
14. 14. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival study (CONSENSUS). N Engl J Med 1987;316:1429-35.
15. 15. Califf RM, Adams KF, McKenna W, et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST). Am Heart J 1997; 134:44-54.
16. 16. Efron B. The jackknife, the bootstrap and other resampling plans. Philadelphia: S.I.A.M.; 1982.
17. 17. Madsen BK, Hansen JF, Stokholm KH, et al. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. Eur Heart J 1994;15:303-10.
18. 18. Dargie HJ, Cleland JGF, Leckie BJ, et al. Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. Circulation 1987;75:98-107.
19. 19. Franciosa JA, Wilen M, Zietsche S, et al. Survival in men with severe chronique left ventricular failure due to either coronary heart disease or idiopatic dilated cardiomyopathy. Am J Cardiol 1983;51:831-6.
20. 20. O'Connor CM, Carson PE, Miller AB, et al. Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival Evaluation. Am J Cardiol 1998;82:881-7.
21. 21. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986;73: 257-67.
22. 22. Packer M, Lee WH, Kessler PD, et al. Role of neurohormonal mecanism in determining survival in patient with severe chronic heart failure. Circulation 1987;75(IV):IV-80-IV-92.
23. 23. Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997;2660-7.
24. 24. Ponikowski P, Anker SD, Chua TP, et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997;79:1645-50.
25. 25. Kannel WB, Cupples A. Epidemiology and risk profile of cardiac failure. Cardiovasc Drugs Ther 1988;2:387-95.
26. 26. Cohn JN, Johnson G, Shabetai R, et al. Ejection fraction, peak exercice oxygen consumption, cardiothoracic ration, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993;87:VI5-VII6.
27. 27. Mancini DM, Eisen H, Kussmaul W, et al. Value of peak exercice oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83: 778-86.
28. 28. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1987;59:634-8.
29. 29. Chastang C, Auquier A, Gremy F. Prognostic Knowledge: interest and methods. Bull Cancer 1980,67:430-6.
30. 30. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991;121:951-7.
31. 31. CIBIS II investigators and comittees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomized study. Lancet 1999;353:9-13.
32. 32. Anonymous. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
33. 33. Cowburn P, Cleland J, Coats A, et al. Risk stratification in chronic heart failure. Eur Heart J 1998;19:696-710.